Tumor Suppressor HIPK2 Regulates Malignant Growth via Phosphorylation of Notch1

Eun-Jung Ann1, Mi-Yeon Kim2, Ji-Hye Yoon1

  • 1Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea.

Cancer Research
|June 24, 2016
PubMed

Insights

The kinase HIPK2 targets Notch1 for degradation, reducing its levels in cancer cells. This discovery offers a potential strategy to inhibit Notch1-driven cancer progression.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • Notch1 receptor is crucial for cancer progression, but its regulatory mechanisms remain unclear.
  • Understanding Notch1 regulation is vital for developing targeted cancer therapies.

Purpose of the Study:

  • To elucidate the role of HIPK2 in regulating Notch1 stability.
  • To identify the mechanism by which HIPK2 controls Notch1 degradation.

Main Methods:

  • Investigated the interaction between HIPK2 and Notch1.
  • Utilized cell-based assays to study Notch1 phosphorylation and degradation.
  • Analyzed the effect of mutations on Notch1 stability under genotoxic stress.

Main Results:

  • HIPK2 phosphorylates Notch1 intracellular domain (Notch1-IC) at T2512, targeting it for Fbw7-dependent proteasomal degradation.
  • Notch1-IC expression is elevated in cancer cells and reduced by HIPK2-mediated degradation under genotoxic stress.
  • Mutations near T2512 confer resistance to Notch1 degradation.

Conclusions:

  • HIPK2 acts as a key regulator of Notch1 stability through phosphorylation-dependent degradation.
  • This pathway represents a potential therapeutic target for cancers driven by Notch1.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.8K
Notch Signaling Pathway03:14

Notch Signaling Pathway

6.4K